Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction
Phase of Trial: Phase IV
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Bayer
- 29 Sep 2017 Status changed from active, no longer recruiting to completed.
- 03 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Aug 2017 Planned End Date changed from 30 Jul 2017 to 8 Sep 2017.